These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31610219)

  • 1. Characterization and protective efficacy of a Salmonella pathogenicity island 2 (SPI2) mutant of Salmonella Paratyphi A.
    Yin J; Cheng Z; Wu Y; He Q; Zhang J; Yang Z; Ding S; Li J; Guo D
    Microb Pathog; 2019 Dec; 137():103795. PubMed ID: 31610219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.
    Gat O; Galen JE; Tennant S; Simon R; Blackwelder WC; Silverman DJ; Pasetti MF; Levine MM
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1373. PubMed ID: 22069504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and protective efficacy of a sptP mutant of Salmonella Paratyphi A.
    Pan P; Zou F; He C; He Q; Yin J
    Immun Inflamm Dis; 2020 Dec; 8(4):774-781. PubMed ID: 33135379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated
    Liu Q; Li P; Luo H; Curtiss R; Kong Q
    Virulence; 2019 Dec; 10(1):82-96. PubMed ID: 31874075
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Concern: Cell-Associated Flagella Enhance the Protection Conferred by Mucosally-Administered Attenuated Salmonella Paratyphi A Vaccines.
    PLOS Neglected Tropical Diseases Editors
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012160. PubMed ID: 38709719
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant SpaO and H1a as immunogens for protection of mice from lethal infection with Salmonella paratyphi A: implications for rational design of typhoid fever vaccines.
    Ruan P; Xia XP; Sun D; Ojcius DM; Mao YF; Yue WY; Yan J
    Vaccine; 2008 Dec; 26(51):6639-44. PubMed ID: 18834913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates.
    Roland KL; Tinge SA; Kochi SK; Thomas LJ; Killeen KP
    Vaccine; 2010 May; 28(21):3679-87. PubMed ID: 20338215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmonella Typhi outer membrane protein STIV is a potential candidate for vaccine development against typhoid and paratyphoid fever.
    Das S; Chowdhury R; Pal A; Okamoto K; Das S
    Immunobiology; 2019 May; 224(3):371-382. PubMed ID: 30952553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of cigR gene on the pathogenicity of Salmonella paratyphi A in vitro and in vivo.
    Yin J; Wang L; Shen R; He J; Li S; Wang H; Cheng Z
    FEMS Microbiol Lett; 2024 Jan; 371():. PubMed ID: 39165135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Salmonella enterica Serovar Pullorum Pathogenicity Island 2 Mutant as a Candidate Live Attenuated Oral Vaccine.
    Yin J; Cheng Z; Wang X; Xu L; Li Q; Geng S; Jiao X
    Clin Vaccine Immunol; 2015 Jul; 22(7):706-10. PubMed ID: 25924763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive immune response induced by the Vi capsular polysaccharide typhoid vaccine against Salmonella Paratyphi strains.
    Pakkanen SH; Kantele JM; Kantele A
    Scand J Immunol; 2014 Mar; 79(3):222-9. PubMed ID: 24383914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of chickens with Salmonella Pathogenicity Island (SPI) 1 and SPI2 defective mutants of Salmonella enterica serovar Enteritidis.
    Matulova M; Havlickova H; Sisak F; Rychlik I
    Vaccine; 2012 Mar; 30(12):2090-7. PubMed ID: 22300724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The anti-Salmonella paratyphi B vaccination].
    Dimache G; Vlădoianu IR; Dimache V; Popescu P; Antonescu O; Mitrea D
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):477-86. PubMed ID: 4999244
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses of Salmonella Paratyphi A Associated Oligosaccharide Antigens and Development towards Anti-Paratyphoid Fever Vaccines.
    Dhara D; Baliban SM; Huo CX; Rashidijahanabad Z; Sears KT; Nick ST; Misra AK; Tennant SM; Huang X
    Chemistry; 2020 Dec; 26(68):15953-15968. PubMed ID: 32578281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.